Adaia Albasanz‐Puig

698 total citations
14 papers, 325 citations indexed

About

Adaia Albasanz‐Puig is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Adaia Albasanz‐Puig has authored 14 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Adaia Albasanz‐Puig's work include Neutropenia and Cancer Infections (4 papers), Cytomegalovirus and herpesvirus research (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Adaia Albasanz‐Puig is often cited by papers focused on Neutropenia and Cancer Infections (4 papers), Cytomegalovirus and herpesvirus research (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Adaia Albasanz‐Puig collaborates with scholars based in Spain, United States and Palestinian Territory. Adaia Albasanz‐Puig's co-authors include Jordi Carratalà, Carlota Gudiol, Errol S. Wijelath, Guillermo Cuervo, Jacqueline Murray, Júlia Laporte-Amargós, Zhao Dong, Pedro Puerta‐Alcalde, Carolina García‐Vidal and Àlex Soriano and has published in prestigious journals such as Neurology, Clinical Infectious Diseases and Biochemical and Biophysical Research Communications.

In The Last Decade

Adaia Albasanz‐Puig

14 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adaia Albasanz‐Puig Spain 9 178 100 76 53 51 14 325
Mariona Calvo Spain 7 179 1.0× 77 0.8× 86 1.1× 21 0.4× 57 1.1× 20 344
Michiya Yokozaki Japan 14 118 0.7× 118 1.2× 39 0.5× 11 0.2× 98 1.9× 37 517
Riva Fineman Israel 11 165 0.9× 99 1.0× 26 0.3× 90 1.7× 124 2.4× 30 501
Paula Yurie Tanaka Brazil 9 168 0.9× 64 0.6× 48 0.6× 16 0.3× 46 0.9× 20 286
Andrea Zimmer United States 7 142 0.8× 81 0.8× 70 0.9× 9 0.2× 24 0.5× 15 265
Ingvill Purr Germany 5 113 0.6× 139 1.4× 82 1.1× 125 2.4× 24 0.5× 6 349
Julien Senécal Canada 10 62 0.3× 140 1.4× 87 1.1× 147 2.8× 22 0.4× 12 505
Tanya O’Neal United States 9 86 0.5× 76 0.8× 55 0.7× 64 1.2× 22 0.4× 11 302
Corinna Hahn‐Ast Germany 13 201 1.1× 187 1.9× 98 1.3× 35 0.7× 18 0.4× 22 492
Mark Hastings United Kingdom 6 250 1.4× 145 1.4× 99 1.3× 28 0.5× 22 0.4× 6 403

Countries citing papers authored by Adaia Albasanz‐Puig

Since Specialization
Citations

This map shows the geographic impact of Adaia Albasanz‐Puig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adaia Albasanz‐Puig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adaia Albasanz‐Puig more than expected).

Fields of papers citing papers by Adaia Albasanz‐Puig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adaia Albasanz‐Puig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adaia Albasanz‐Puig. The network helps show where Adaia Albasanz‐Puig may publish in the future.

Co-authorship network of co-authors of Adaia Albasanz‐Puig

This figure shows the co-authorship network connecting the top 25 collaborators of Adaia Albasanz‐Puig. A scholar is included among the top collaborators of Adaia Albasanz‐Puig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adaia Albasanz‐Puig. Adaia Albasanz‐Puig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Navarro, Vı́ctor, Moraima Jiménez, Marc Bosch, et al.. (2025). Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders. Blood Advances. 9(16). 4180–4189. 1 indexed citations
2.
Medina, Irene García, Cecilia Carpio, Isabel Ruíz-Camps, et al.. (2023). Adenovirus-Induced Hemorrhagic Cystitis After CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in a Patient with Large B-Cell Lymphoma. Immunotherapy. 15(16). 1369–1374. 1 indexed citations
3.
Iacoboni, Gloria, Berta Pernas, Juliana Esperalba, et al.. (2022). Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy. Transplantation and Cellular Therapy. 28(12). 851.e1–851.e8. 30 indexed citations
4.
Salas, María Queralt, Alberto Mussetti, Carmen Muñoz, et al.. (2021). Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience. Hematology Transfusion and Cell Therapy. 44(3). 440–443. 3 indexed citations
5.
Gudiol, Carlota, Adaia Albasanz‐Puig, Guillermo Cuervo, & Jordi Carratalà. (2021). Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance. Frontiers in Medicine. 8. 636547–636547. 52 indexed citations
6.
Albasanz‐Puig, Adaia, Paula Suanzes, Juliana Esperalba, et al.. (2021). Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48‐week follow‐up study. HIV Medicine. 22(8). 682–689. 7 indexed citations
7.
8.
Albasanz‐Puig, Adaia, Dolors Rodríguez-Pardo, Carles Pigrau, et al.. (2020). Necrotizing fasciitis in haematological patients: a different scenario. Annals of Hematology. 99(8). 1741–1747. 8 indexed citations
9.
Martínez‐Nadal, Gemma, Pedro Puerta‐Alcalde, Carlota Gudiol, et al.. (2019). Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance. Clinical Infectious Diseases. 70(6). 1068–1074. 101 indexed citations
10.
Gudiol, Carlota, Montserrat Arnán, Manuela Aguilar‐Guisado, et al.. (2019). A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients. Antimicrobial Agents and Chemotherapy. 64(2). 15 indexed citations
11.
Pappolla, Agustín, Luciana Midaglia, Adaia Albasanz‐Puig, et al.. (2018). Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis. Neurology. 92(6). 296–298. 11 indexed citations
12.
Albasanz‐Puig, Adaia, Jacqueline Murray, Mayumi Yagi, et al.. (2014). Modulation of vascular smooth muscle cell phenotype by STAT-1 and STAT-3. Atherosclerosis. 234(1). 169–175. 24 indexed citations
13.
Albasanz‐Puig, Adaia, et al.. (2012). Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 428(1). 179–184. 23 indexed citations
14.
Albasanz‐Puig, Adaia, Jacqueline Murray, Michael R. Preusch, et al.. (2011). Oncostatin M is expressed in atherosclerotic lesions: A role for Oncostatin M in the pathogenesis of atherosclerosis. Atherosclerosis. 216(2). 292–298. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariona Calvo Breakdown of academic impact, for papers by Michiya Yokozaki Breakdown of academic impact, for papers by Riva Fineman Breakdown of academic impact, for papers by Paula Yurie Tanaka Breakdown of academic impact, for papers by Andrea Zimmer Breakdown of academic impact, for papers by Ingvill Purr Breakdown of academic impact, for papers by Julien Senécal Breakdown of academic impact, for papers by Tanya O’Neal Breakdown of academic impact, for papers by Corinna Hahn‐Ast Breakdown of academic impact, for papers by Mark Hastings
Rankless by CCL
2026